Experience of the Irish National Centre for hereditary haemorrhagic telangiectasia 2003-2008

Ni Bhuachalla, C. F., O' Connor, T. M., Murphy, M., Colwell, N. and Brady, A. (2010) Experience of the Irish National Centre for hereditary haemorrhagic telangiectasia 2003-2008. Respiratory Medicine, 104 8: 1218-1224. doi:10.1016/j.rmed.2010.03.003


Author Ni Bhuachalla, C. F.
O' Connor, T. M.
Murphy, M.
Colwell, N.
Brady, A.
Title Experience of the Irish National Centre for hereditary haemorrhagic telangiectasia 2003-2008
Journal name Respiratory Medicine   Check publisher's open access policy
ISSN 0954-6111
1532-3064
Publication date 2010
Year available 2010
Sub-type Article (original research)
DOI 10.1016/j.rmed.2010.03.003
Open Access Status
Volume 104
Issue 8
Start page 1218
End page 1224
Total pages 7
Place of publication Camden, London, United Kingdom
Publisher Elsevier Ltd
Collection year 2010
Language eng
Subject 2740 Pulmonary and Respiratory Medicine
Abstract Hereditary haemorrhagic telangiectasia (HHT) is a group of autosomal dominant disorders of vascular structure. The Irish National Centre for HHT at the Mercy University Hospital, Cork, Ireland was founded in 2003. From 2003 to 2008, screening of 164 patients with contrast echocardiography, thoracic computerised tomography (CT) and cerebral magnetic resonance imaging (MRI) has identified 88 patients with definite HHT, 72 (82%) of whom had epistaxis, 70 (80%) had telangiectasia and 81 (92%) had a first-degree relative with HHT. We sought to describe the manifestations of HHT in an Irish population and to determine differences between internationally reported data. The HHT patient database was analysed to describe demographics, clinical manifestations and interventional procedures performed in all referred patients. Contrast echocardiography and/or CT were performed in 86 patients with definite HHT, identifying 27 patients (31%) with pulmonary arteriovenous malformations (pAVMs). Nineteen patients with single or multiple pAVMs had 28 embolisation procedures performed, with 1-6 pAVMs embolised per procedure. Cerebral MRI was performed in 78 (89%) patients and 2 (2.3%) had cerebral arteriovenous malformations (cAVMs). HHT prevalence is thought to be 1 in 2500-8000, suggesting that there are many undiagnosed cases in Irish patients. Internationally published data suggest a prevalence of 15-35% for pAVMs and 10-23% for cAVMs in patients with HHT. While the prevalence of pAVMs in our group is consistent with these data, the prevalence of cAVMs is considerably lower, suggesting that Irish patients with HHT may differ genotypically and phenotypically from those in other countries.
Keyword Cerebral arteriovenous malformation
Embolisation
Hereditary haemorrhagic telangiectasia
Pulmonary arteriovenous malformation
Rendu Osler Weber syndrome
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Scopus Citation Count Cited 3 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Fri, 01 Aug 2014, 18:44:44 EST by System User on behalf of School of Medicine